Oncology & Cancer
Adolescent glioma subtype responds to CDK4/6 inhibitor
CDK4/6 inhibitors, which are already FDA approved for the treatment of other forms of cancer, show early signs of promise in the treatment of a subtype of pediatric high-grade glioma, according to new research from Dana-Farber ...
Sep 4, 2024
0
0
